Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Obesity (Silver Spring, Md.)
|
December 1, 2006
ABCA1 single nucleotide polymorphisms on high-density lipoprotein-cholesterol and overweight: the D.E.S.I.R. study
Isabelle Porchay, Franck Péan, Naïma Bellili, et al.
Cancer Chemotherapy and Pharmacology
|
January 2, 2021
Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients
Nastja Lunar, Marie-Christine Etienne-Grimaldi, Pauline Macaire, et al.
Anti-Cancer Drugs
|
September 16, 2005
Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: influence of protein binding
Bernard Royer, Emmanuel Guardiola, Emmanuel Polycarpe, et al.
Anti-Cancer Drugs
|
December 25, 2009
Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study
Emmanuel Guardiola, Bruno Chauffert, Delphine Delroeux, et al.
Seminars in Oncology
|
September 20, 2017
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: The multiparametric approach is not convincing
Marie-Christine Etienne-Grimaldi, Chantal Barin Le Guellec, Jean-Christophe Boyer, et al.
Anti-Cancer Drugs
|
September 22, 2010
Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors
Antoine Thiery-Vuillemin, Erion Dobi, Thierry Nguyen, et al.
Oncotarget
|
November 22, 2018
Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment
Sindy Vrecko, David Guenat, Patricia Mercier-Letondal, et al.
Pharmaceutics
|
October 23, 2021
Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients
Alexandre Le Marouille, Emma Petit, Courèche Kaderbhaï, et al.
Therapeutic Advances in Medical Oncology
|
January 16, 2023
Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients
Sidonie Callon, Mathias Brugel, Damien Botsen, et al.
Therapeutic Advances in Medical Oncology
|
April 26, 2024
Improving olaparib exposure to optimize adverse effects management
Marylise Sterlé, Alicja Puszkiel, Chloé Burlot, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Obesity (Silver Spring, Md.)
|
December 1, 2006
ABCA1 single nucleotide polymorphisms on high-density lipoprotein-cholesterol and overweight: the D.E.S.I.R. study
Isabelle Porchay, Franck Péan, Naïma Bellili, et al.
Cancer Chemotherapy and Pharmacology
|
January 2, 2021
Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients
Nastja Lunar, Marie-Christine Etienne-Grimaldi, Pauline Macaire, et al.
Anti-Cancer Drugs
|
September 16, 2005
Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: influence of protein binding
Bernard Royer, Emmanuel Guardiola, Emmanuel Polycarpe, et al.
Anti-Cancer Drugs
|
December 25, 2009
Intraoperative chemotherapy with cisplatin and epinephrine after cytoreductive surgery in patients with recurrent ovarian cancer: a phase I study
Emmanuel Guardiola, Bruno Chauffert, Delphine Delroeux, et al.
Seminars in Oncology
|
September 20, 2017
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: The multiparametric approach is not convincing
Marie-Christine Etienne-Grimaldi, Chantal Barin Le Guellec, Jean-Christophe Boyer, et al.
Anti-Cancer Drugs
|
September 22, 2010
Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors
Antoine Thiery-Vuillemin, Erion Dobi, Thierry Nguyen, et al.
Oncotarget
|
November 22, 2018
Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment
Sindy Vrecko, David Guenat, Patricia Mercier-Letondal, et al.
Pharmaceutics
|
October 23, 2021
Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients
Alexandre Le Marouille, Emma Petit, Courèche Kaderbhaï, et al.
Therapeutic Advances in Medical Oncology
|
January 16, 2023
Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients
Sidonie Callon, Mathias Brugel, Damien Botsen, et al.
Therapeutic Advances in Medical Oncology
|
April 26, 2024
Improving olaparib exposure to optimize adverse effects management
Marylise Sterlé, Alicja Puszkiel, Chloé Burlot, et al.
Page
of 7